Search

everythinglearnresearchcommunity

for

Search:↓

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

People with hidradenitis suppurativa often have lower vitamin D levels, weaker hip bones, and altered bone metabolism markers.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

Blocking interferon-gamma might help treat various autoimmune diseases.

New cytokine-targeted therapies show promise for treating alopecia areata.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Borneol Essential Oil could be a natural and safe acne treatment.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Early treatment of acne is crucial to prevent scarring and psychological effects.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.